Kymera Therapeutics, Inc. (KYMR) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$81.44
Day's range
$85.71

Kymera Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 05/15/2026 11.70 M $974.49 M   31.04% 13.86%
BAKER BROS. ADVISORS LP 05/15/2026 8.66 M $721.06 M   0.00% 10.26%
AVORO CAPITAL ADVISORS LLC 05/15/2026 7.47 M $622.57 M   0.00% 8.86%
PRICE T ROWE ASSOCIATES INC /MD/ 05/15/2026 6.06 M $504.81 M   -1.60% 7.18%
BVF INC/IL 05/15/2026 5.50 M $458.32 M   0.00% 6.52%
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 05/15/2026 5.46 M $455.18 M   767.81% 6.48%
BLACKROCK, INC. 05/13/2026 5.06 M $421.52 M   1.13% 6.00%
ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC 05/14/2026 4.58 M $381.30 M   -1.76% 5.42%
WELLINGTON MANAGEMENT GROUP LLP 05/15/2026 3.89 M $323.97 M   -11.86% 4.61%
SIREN, L.L.C. 05/14/2026 3.19 M $265.43 M   -3.04% 3.78%
05/15/2026 2.88 M $239.90 M   100.00% 3.41%
05/08/2026 2.87 M $239.38 M   100.00% 3.41%
STATE STREET CORP 05/15/2026 2.39 M $199.04 M   8.14% 2.83%
CAPITAL RESEARCH GLOBAL INVESTORS 05/13/2026 1.67 M $139.37 M   7.21% 1.98%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 1.65 M $137.07 M   16.08% 1.95%
DRIEHAUS CAPITAL MANAGEMENT LLC 05/15/2026 1.04 M $86.92 M   -2.40% 1.24%
UBS GROUP AG 05/05/2026 1.02 M $85.28 M   38.92% 1.21%
GOLDMAN SACHS GROUP INC 05/15/2026 888.41 K $74.00 M   20.01% 1.05%
ALLIANCEBERNSTEIN L.P. 05/15/2026 888.04 K $69.10 M   -6.73% 1.05%
UBS ASSET MANAGEMENT AMERICAS INC 05/13/2026 875.87 K $72.95 M   -4.01% 1.04%
HOLOCENE ADVISORS, LP 05/15/2026 836.76 K $69.69 M   9.93% 0.99%
MERCK & CO., INC. 05/13/2026 772.17 K $64.31 M   0.00% 0.92%
FRONTIER CAPITAL MANAGEMENT CO LLC 05/15/2026 759.85 K $63.29 M   19.48% 0.90%
COMMODORE CAPITAL LP 05/15/2026 750.00 K $62.47 M   0.00% 0.89%
EVENTIDE ASSET MANAGEMENT, LLC 05/15/2026 626.93 K $52.21 M   0.08% 0.74%
DIMENSIONAL FUND ADVISORS LP 05/07/2026 592.88 K $49.36 M   -4.99% 0.70%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 05/15/2026 561.17 K $46.74 M   0.00% 0.67%
FEDERATED HERMES, INC. 05/11/2026 536.68 K $44.70 M   -29.75% 0.64%
JENNISON ASSOCIATES LLC 05/06/2026 509.00 K $42.39 M   2.48% 0.60%
ROCK SPRINGS CAPITAL MANAGEMENT LP 05/15/2026 496.87 K $41.38 M   0.00% 0.59%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 495.26 K $41.25 M   -0.35% 0.59%
NORTHERN TRUST CORP 05/14/2026 494.44 K $41.18 M   5.87% 0.59%
PICTET ASSET MANAGEMENT HOLDING SA 04/22/2026 468.73 K $38.76 M   -2.99% 0.56%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 427.38 K $35.60 M   100.00% 0.51%
OCTAGON CAPITAL ADVISORS LP 05/15/2026 425.00 K $35.40 M   -20.56% 0.50%
FRANKLIN RESOURCES INC 05/13/2026 361.77 K $30.13 M   2.03% 0.43%
ALYESKA INVESTMENT GROUP, L.P. 05/15/2026 342.70 K $28.54 M   -7.85% 0.41%
BRAIDWELL LP 05/15/2026 337.56 K $28.12 M   -25.69% 0.40%
ADAGE CAPITAL PARTNERS GP, L.L.C. 05/15/2026 335.00 K $27.90 M   -22.09% 0.40%
BOXER CAPITAL MANAGEMENT, LLC 05/15/2026 329.10 K $27.41 M   0.00% 0.39%
BANK OF AMERICA CORP /DE/ 05/18/2026 289.42 K $24.11 M   -14.63% 0.34%
TD ASSET MANAGEMENT INC 05/11/2026 287.10 K $23.91 M   29.81% 0.34%
BNP PARIBAS ARBITRAGE, SNC 05/12/2026 285.87 K $23.81 M   3,149.27% 0.34%
NEXTECH INVEST, LTD. 05/15/2026 278.90 K $23.23 M   0.00% 0.33%
TWO SIGMA INVESTMENTS, LP 05/15/2026 256.50 K $21.36 M   -3.40% 0.30%
FIRST TURN MANAGEMENT, LLC 05/15/2026 254.67 K $21.21 M   23.36% 0.30%
RTW INVESTMENTS, LP 05/15/2026 240.00 K $19.99 M   0.00% 0.28%
GILDER GAGNON HOWE & CO LLC 05/15/2026 235.43 K $19.61 M   -1.87% 0.28%
POLAR CAPITAL HOLDINGS PLC 05/15/2026 215.20 K $17.92 M   7.09% 0.26%
MORGAN STANLEY 05/15/2026 212.70 K $17.72 M   -22.38% 0.25%

Kymera Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 312 institutional investors and hedge funds held shares of Kymera Therapeutics Inc. The most heavily invested institutionals were:

FMR LLC: 11.7 M

BAKER BROS. ADVISORS LP: 8.66 M

Avoro Capital Advisors LLC: 7.47 M

PRICE T ROWE ASSOCIATES INC /MD/: 6.06 M

BVF INC/IL: 5.5 M

T. Rowe Price Investment Management, Inc.: 5.46 M

114.10% of Kymera Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 103.21 M shares in the last 24 months. This purchase volume represents approximately $8.78 B in transactions.